Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rerum Novarum
Appenzell, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
Rerum Novarum is a biotechnology and nutraceutical company primarily known for its development and commercialization of the 'Rerum' compound, a complex of chondroitin sulfate, oleic acid, and vitamins D3 and D2. The company focuses on products designed to support the immune system, specifically targeting macrophage activation and the vitamin D receptor pathway. Its flagship product is marketed as a next-generation macrophage activating factor (MAF) substitute, intended for use in various chronic conditions including autism, chronic fatigue, and immune-related disorders. Rerum Novarum operates within the intersection of alternative medicine and biotechnology, providing specialized supplements and protocols to healthcare practitioners and patients globally.
- Therapeutic areas
- PsychiatryImmunologyNeurologyOncology
- Modalities
- Small moleculePeptidesNutraceutical
- Industry
- Food & Nutrition
02
Partnerships
Klinghardt Institute
Beyond the preview
Go deeper on Rerum Novarum.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rerum Novarum.